Boston Scientific Withdraws 2026 Forecast After Cyberattack Disrupts Operations

Boston Scientific Corp. has warned that a recent cybersecurity incident will likely have a material impact on its financial results, forcing the company to withdraw its previous guidance for the third quarter and full-year 2026.

Financial Guidance Withdrawn

In a regulatory filing on Tuesday, the medical device manufacturer stated it is unlikely to meet its previously issued sales and adjusted profit forecast for both the third quarter and the full year. The company attributed the expected shortfall to significant operational disruptions stemming from the cyberattack.

The incident has reportedly affected manufacturing processes and the company's ability to ship orders globally. A material impact suggests the financial consequences are significant enough to influence an investor's decision-making.

Ad

Market Reaction and Impact

Investors reacted swiftly to the disclosure, with Boston Scientific shares falling 4.5% in premarket trading on Tuesday. The withdrawal of financial guidance introduces a high degree of uncertainty for shareholders regarding the company's near-term performance and the full scope of the incident's costs.

This event highlights the increasing operational and financial risks that cybersecurity threats pose to multinational corporations, particularly those with complex manufacturing and supply chains. Boston Scientific has not yet provided a detailed timeline for the full restoration of its systems or a revised financial outlook.